Tag - pharmaceuticals

 
Menu
Search
 
August 15, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
BUSINESS
Mar 4, 2020
Japan's largest drugmaker working to develop virus treatment, Dow Jones reports
Takeda Pharmaceutical Co. is developing an experimental therapy for the novel coronavirus with the goal of making it available in 9 to 18 months, the nation's largest drugmaker said.
BUSINESS
Feb 26, 2020
U.S. begins first coronavirus clinical trial testing Gilead's experimental drug
U.S. health officials said on Tuesday the first clinical trial testing Gilead Sciences Inc.'s experimental antiviral drug, remdesivir, in hospitalized patients with the coronavirus has started.
Japan Times
BUSINESS
Feb 24, 2020
Boris Johnson to begin trade talks with U.S. in two weeks, Telegraph reports
British Prime Minister Boris Johnson is prepared to begin trade talks with the United States within the coming two weeks, the Telegraph reported on Sunday.
Japan Times
BUSINESS / Companies
Feb 20, 2020
As COVID-19 spreads, Takeda CEO urges more industry investment in vaccines
The spread of novel coronavirus infections is starting to make one thing clear: More vaccine investment is needed, the CEO of Asia's biggest drugmaker said.
Japan Times
WORLD / Science & Health
Feb 19, 2020
In fighting outbreaks like COVID-19, Big Pharma struggles to get out front
Sanofi has joined the race to combat coronavirus as the outbreak is kindling fears of a pandemic. The question is whether its effort will prove more effective than some of Big Pharma's past attempts to tackle dangerous new pathogens.
Japan Times
ASIA PACIFIC / Science & Health
Feb 18, 2020
Lung biopsy of deceased China patient shows SARS-like damage
Doctors studying a 50-year-old man who died in China last month from the new coronavirus found that the disease caused lung damage reminiscent of two prior coronavirus-related outbreaks, SARS and MERS.
Japan Times
ASIA PACIFIC / Science & Health
Feb 14, 2020
Gilead drug prevents type of coronavirus in monkeys, raising hope for China trials
An experimental Gilead Sciences antiviral drug prevented disease and reduced the severity of symptoms in monkeys infected with Middle East respiratory syndrome (MERS), an infection closely related to the fast-spreading coronavirus that originated in China, a study published on Thursday found.
Japan Times
ASIA PACIFIC / Science & Health
Feb 13, 2020
Results from Chinese drug trials for coronavirus due in weeks: expert
Chinese scientists are testing two antiviral drugs against the new coronavirus and preliminary clinical trial results are weeks away, the co-chair of a World Health Organization (WHO) meeting said on Wednesday.
Japan Times
ASIA PACIFIC / Science & Health
Feb 6, 2020
Drugmakers see long road ahead in coronavirus vaccine race
Drugmakers racing to find a vaccine or effective treatment for the deadly new coronavirus cautioned that they have a long way to go.
Japan Times
BUSINESS
Jul 12, 2019
White House scraps key plan to lower U.S. drug prices, may target makers
The Trump administration on Thursday scrapped one of its most ambitious proposals for lowering prescription medicine prices, backing down from a policy aimed at health insurers and raising the possibility of new measures focused on drug makers.
Japan Times
WORLD / Science & Health
Jun 20, 2019
Eroding trust in vaccines leaves populations vulnerable, global study finds
Trust in vaccines — one of the world's most effective and widely-used medical products — is highest in poorer countries but weaker in wealthier ones where skepticism has allowed outbreaks of diseases such as measles to persist, a global study released Wednesday has found.
WORLD / Science & Health
May 16, 2019
Scientists launch push to beat cancer's ability to adapt against treatments
Cancer scientists in Britain are launching what they call the world's first "Darwinian" drug development program in a bid to get ahead of cancer's ability to become resistant to even the newest treatments and recur in many patients.
Japan Times
BUSINESS / Companies
Mar 29, 2019
AstraZeneca bets $6.9 billion that Daiichi Sankyo therapy will transform cancer treatment
Britain's AstraZeneca's biggest deal in recent memory give it access to the Japanese drugmaker's promising but difficult to pronounce cancer treatment: trastuzumab deruxtecan.
BUSINESS
Jan 2, 2019
China's generic drug makers struggle to survive bulk-buy policy onslaught
Even after a plunge last month that wiped $46 billion off Chinese health-care stocks, domestic drug makers may be far from their floor as a Beijing-led policy shift gathers pace.
Japan Times
ASIA PACIFIC / Science & Health
Oct 18, 2018
A blue pill is stopping HIV, world-first study shows
An antiviral pill taken daily by thousands of men across Sydney and other parts of Australia led to a globally unprecedented reduction in new HIV cases, showing that a targeted, preventative approach may accelerate progress on ending the AIDS epidemic.
BUSINESS
Jul 7, 2018
Alzheimer's research gets glimmer of hope, but not for first time
For the few drugmakers that haven't given up on the decadeslong, elusive quest for a cure of Alzheimer's disease, each piece of news is a small signpost along a possible path to success — and billions of dollars in potential sales.
Japan to revise consumption tax exemption for overseas tourists
Tourists walk through Nakamise shopping street near Sensoji Temple in Tokyo in April
Japan's tourism industry hit by cancellations after megaquake alert
A beach closed due to a megaquake alert in Hiratsuka, Kanagawa Prefecture, from Friday to Thursday.
Focus shifts to incoming typhoon as Tropical Storm Maria dissipates
Newly formed Tropical Storm Ampil, which is forecast to approach eastern Japan this weekend, is seen on the left side of this satellite image.
Kishida to step down in September in bid to show ‘LDP has changed’
Prime Minister Fumio Kishida speaks during a news conference Wednesday at the Prime Minister's Office in Tokyo.
Publisher finds surprise audience after translating history textbooks
Yamakawa Shuppansha president Takeshi Nozawa holds the publisher's textbook on Japanese history — used in high schools across Japan — alongside the new English version in Tokyo on May 23.
Economic security is about strengthening and sustaining growth, former minister says
Former economic security minister Takayuki Kobayashi says changes in the international balance of power, along with deepening economic interdependence, have led some countries to attempt to use their economic power to impose their will on others.
Ice bandanas, convenience store breaks: Running under Japan’s summer sun
Blistering heat is becoming a fixture of summer in Japan, but a few tweaks to your routine can make your outdoor runs bearable — if not enjoyable — until cooler temperatures return.
Japan issued its first-ever megaquake alert. What does that mean?
Naoshi Hirata (center), chairman of a committee tasked with evaluating the risk of a Nankai Trough earthquake, speaks at a news conference in Tokyo on Friday.
France brings down the curtain on its Olympic party with Tom Cruise and Leon Marchand
Fireworks are set off during the closing ceremony of the 2024 Paris Olympics at Stade de France in Saint-Denis on Sunday.
Japan fuels U.S. LNG boom even as climate targets and impacts loom
Flaring at the Cameron LNG export terminal in Hackberry, Louisiana. Flaring, a common sight at LNG plants, is a controlled burning of gas for reasons ranging from depressurizing equipment to disposing of gas that can’t be used. The practice is a "waste of money" and negatively impacts climate change and human health, says the International Energy Agency.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Sociologist Gracia Liu-Farrer argues that even though immigration doesn't figure into Japan's autobiography, it is more of a self-perception than a reality.
In search of the ‘Japanese dream’
By Thu-Huong Ha

SUSTAINABLE JAPAN

Azabudai Hills, Tokyo’s green new downtown ‘village’
Azabudai Hills, Tokyo’s green new downtown ‘village’

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER